Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Cresol is a small molecule aromatic organic compound used primarily as a disinfectant and antiseptic. It exists as three isomers (ortho-, meta-, and para-cresol), often found together in mixtures derived from coal tar or produced synthetically. Cresols are strong germicides effective at low concentrations and have been used in dental procedures to remove dental pulp. They are also utilized industrially as solvents, preservatives (including wood preservatives), intermediates for the synthesis of plastics, pesticides, pharmaceuticals, dyes, antioxidants (such as butylated hydroxytoluene), and other chemicals. The mechanism of action for its disinfectant properties involves disruption of microbial cell membranes and denaturation of proteins. Cresols are toxic at high concentrations by ingestion or dermal exposure; they can cause severe burns and systemic toxicity[1][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Cresol.